Stokes Capital Advisors LLC trimmed its position in Oracle Corporation (NYSE:ORCL – Free Report) by 12.4% in the first quarter, HoldingsChannel.com reports. The firm owned 30,842 shares of the enterprise software provider’s stock after selling 4,379 shares during the quarter. Stokes Capital Advisors LLC’s holdings in Oracle were worth $4,537,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of Oracle in the fourth quarter valued at $4,336,031,000. Capital Research Global Investors boosted its stake in Oracle by 29.3% during the fourth quarter. Capital Research Global Investors now owns 30,137,126 shares of the enterprise software provider’s stock valued at $5,874,070,000 after buying an additional 6,826,299 shares in the last quarter. Vanguard Group Inc. grew its holdings in Oracle by 3.5% during the fourth quarter. Vanguard Group Inc. now owns 174,802,084 shares of the enterprise software provider’s stock worth $34,070,674,000 after acquiring an additional 5,841,584 shares during the period. Cardano Risk Management B.V. raised its position in Oracle by 882.3% in the fourth quarter. Cardano Risk Management B.V. now owns 4,991,010 shares of the enterprise software provider’s stock worth $972,798,000 after acquiring an additional 4,482,934 shares in the last quarter. Finally, American Century Companies Inc. raised its position in Oracle by 333.7% in the third quarter. American Century Companies Inc. now owns 5,238,006 shares of the enterprise software provider’s stock worth $1,473,137,000 after acquiring an additional 4,030,382 shares in the last quarter. 42.44% of the stock is owned by institutional investors.
Oracle Stock Down 3.0%
Oracle stock opened at $152.82 on Friday. The firm has a market cap of $440.19 billion, a PE ratio of 26.21, a P/E/G ratio of 0.99 and a beta of 1.65. The company has a debt-to-equity ratio of 3.21, a quick ratio of 1.35 and a current ratio of 1.12. The firm’s 50 day moving average price is $189.96 and its two-hundred day moving average price is $175.88. Oracle Corporation has a twelve month low of $134.57 and a twelve month high of $345.72.
Oracle Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 24th. Shareholders of record on Friday, July 10th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Friday, July 10th. Oracle’s dividend payout ratio is presently 34.31%.
Insider Buying and Selling at Oracle
In other news, EVP Stuart Levey sold 15,000 shares of Oracle stock in a transaction dated Thursday, April 16th. The stock was sold at an average price of $176.19, for a total transaction of $2,642,850.00. Following the completion of the sale, the executive vice president directly owned 3,429 shares in the company, valued at $604,155.51. The trade was a 81.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 40.90% of the stock is owned by company insiders.
Key Oracle News
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle reported a record $638 billion backlog, which strengthens long-term revenue visibility and supports the bull case that AI cloud demand is translating into future sales. Oracle’s Contract Backlog Swells: Is Long-Term Revenue Growth Secured?
- Positive Sentiment: Oracle strengthened its defense ecosystem by adding new companies focused on mission-ready AI, cyber, and secure cloud capabilities, highlighting expanding demand for Oracle’s infrastructure and AI platform. Oracle Strengthens Defense Ecosystem to Help Emerging Technology Companies Scale Mission-Ready Capabilities
- Positive Sentiment: Oracle Health announced an AI collaboration with Theator, extending Oracle’s cloud and AI footprint into surgical intelligence and healthcare workflow automation. Oracle Health Extends AI into the Operating Room in Collaboration with Theator
- Neutral Sentiment: Several articles argued that Oracle could still be a major long-term AI winner, but these were mostly opinion pieces and valuation debates rather than new hard fundamentals. Can Oracle Become a $1 Trillion Company?
- Negative Sentiment: Oracle cut about 21,000 jobs, and the layoffs have fueled investor worries that the company’s AI transition is coming with disruption, restructuring risk, and potential pressure on sentiment. Oracle Reveals 21,000 Job Cuts as AI Adoption Reshapes Workforce
- Negative Sentiment: Bearish commentary also highlighted Oracle’s growing capital intensity, AI spending, and a warning that preferred-stock conversions or ATM issuance could dilute shareholders and weigh on the stock. Oracle: Becoming A Highly Capital-Intensive NG-Dependent Wholesale Colocation Utility (Rating Downgrade)
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the stock. BMO Capital Markets raised their price objective on shares of Oracle from $200.00 to $220.00 and gave the company an “outperform” rating in a research report on Thursday, June 11th. DA Davidson increased their target price on shares of Oracle from $200.00 to $225.00 and gave the company a “buy” rating in a research note on Thursday, June 11th. Morgan Stanley restated a “mixed” rating on shares of Oracle in a report on Thursday, June 11th. Moffett Nathanson set a $325.00 price target on shares of Oracle in a research report on Thursday, June 11th. Finally, UBS Group upped their price target on Oracle from $250.00 to $285.00 and gave the company a “buy” rating in a report on Tuesday, June 2nd. Two investment analysts have rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $268.27.
Get Our Latest Analysis on Oracle
Oracle Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
See Also
- Five stocks we like better than Oracle
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
